. 2020 Aug 14;28(2):185–197. doi: 10.4103/ipj.ipj_3_19

Table 5.

Comparison of reduction in Cassidy Scale for Manic States scores across the three treatment groups

CSMS	Treatment group	Mean±SD	df	F	P
Reduction in CSMS up to the 1^st week	Lithium	20.52±9.19	2	1.58	0.213
	Carbamazepine	20.20±7.11
	Sodium valproate	18.35±6.82
Reduction in CSMS up to the 2^nd week	Lithium	27.02±11.92	2	3.26	0.045
	Carbamazepine	27.83±9.09
	Sodium valproate	22.00±12.99
Reduction in CSMS up to the 3^rd week	Lithium	28.11±13.33	2	1.95	0.150
	Carbamazepine	29.06±11.21
	Sodium valproate	23.65±15.02
Reduction in CSMS up to the 4^th week	Lithium	28.08±14.10	2	4.51	0.014
	Carbamazepine	27.66±12.70
	Sodium valproate	22.30±14.00
Reduction in CSMS up to the 5^th week	Lithium	31.73±12.68	2	3.31	0.043
	Carbamazepine	25.05±14.51
	Sodium valproate	36.47±14.20

CSMS – Cassidy scale for manic states; SD – Standard deviation; df – Degree of freedom; P<0.05; F – ANOVA value